- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Bopindolol is a beta-blocker drug used to treat cardiovascular diseases such as hypertension, angina, and arrhythmias. It works by blocking the action of certain natural substances in the body, such as epinephrine, that can increase heart rate and blood pressure. Bopindolol is usually taken orally, but can also be administered intravenously. It is generally well tolerated, with few side effects.
Bopindolol is a relatively new drug, having been approved by the US Food and Drug Administration in 2019. It is currently available in the United States, Canada, and Europe. It is used to treat a variety of cardiovascular conditions, including hypertension, angina, and arrhythmias.
The market for bopindolol is growing, as more people are being diagnosed with cardiovascular diseases. It is expected to continue to grow in the coming years, as more people are diagnosed and more treatments become available.
Some companies in the bopindolol market include Merck, Pfizer, Novartis, and Sanofi. Show Less Read more